Ceva and Mineralys Therapeutics Set Q2 2026 Earnings Release Dates

Semiconductor firm Ceva (NASDAQ:CEVA) is scheduled to publish its Q2 2026 earnings before the market opens on Monday, August 10, 2026. Analysts project earnings of $0.07 per share and revenue of $28.138 billion for the quarter.

Biopharmaceutical company Mineralys Therapeutics (NASDAQ:MLYS) will release its Q2 2026 results after the market closes on Tuesday, August 11, 2026. Forecasts call for a loss of $0.5486 per share. Both companies will host conference calls on the respective dates to discuss the outcomes.